CAMP
CalAmp Corp provides wireless communications solutions applications to customers. Its business activities are organized into its Wireless DataCom and Satellite business segments.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Momentum (C-).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C+ (2.7) | B- (3.1) | C+ (2.5) | C- (1.9) | C+ (2.6) | C+ (2.6) |
| 2026-11-10 | C+ (2.6) | B- (2.9) | C+ (2.5) | C+ (2.8) | C+ (2.6) | C+ (2.7) |
| 2026-11-03 | C+ (2.7) | C- (2.1) | C- (2.0) | C+ (2.8) | C+ (2.7) | C (2.5) |
| 2026-10-27 | C+ (2.7) | C- (2.1) | C- (2.0) | C+ (2.6) | C+ (2.6) | C (2.4) |
| 2026-10-20 | C+ (2.7) | C- (2.1) | C- (2.0) | B- (2.9) | C+ (2.6) | C (2.5) |